Hideki Garren News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hideki garren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hideki Garren Today - Breaking & Trending Today

Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript

Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript February 15, 2024 Prothena Corporation plc misses on earnings expectations. Reported EPS is $-1.26 EPS, expectations were $-1.23. PRTA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day ladies and […] ....

Tran Nguyen , Hideki Garren , Movement Disorder Study Congress , Novo Nordisk , Promising Chinese Stocks According , Prothena Corporation , Lzheimer 39s Disease , Clinical Programs , Gene Kinney , Mark Johnson , Rasinezumab Roche , Al Amyloidosis , Financial Results , Clinical Trial , Phase 2 Clinical Trial , Novo Nordisk ,

Penserra Capital Management LLC Makes New $211,000 Investment in Prothena Co. plc (NASDAQ:PRTA)

Penserra Capital Management LLC bought a new position in shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,104 shares of the biotechnology company’s stock, valued at approximately $211,000. Several other […] ....

United States , Hideki Garren , Carold Karp , Northern Trust Corp , Osaic Holdings Inc , Cantor Fitzgerald , Moran Wealth Management , Prothena Corporation , Prothena Co , Prothena Company Profile , Proshare Advisors , Exchange Commission , Penserra Capital Management , Metlife Investment Management , Free Report , Trust Corp , Life Investment Management , Share Advisors , Get Free Report , Prothena Daily , Nasdaq Prta , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Prothena (NASDAQ:PRTA) PT Lowered to $81.00

Prothena (NASDAQ:PRTA – Get Free Report) had its target price lowered by JMP Securities from $83.00 to $81.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has a “market outperform” rating on the biotechnology company’s stock. JMP Securities’ price target indicates a potential upside of 115.71% from the stock’s previous close. […] ....

United States , Hideki Garren , Karinl Walker , Cantor Fitzgerald , Td Asset Management Inc , Jennison Associates , Prothena Corporation , China Universal Asset Management Co , Allspring Global Investments Holdings , Get Free Report , Retirement System , Universal Asset Management , Global Investments Holdings , Management Inc , Prothena Daily , Nasdaq Prta , Lower Price Target , Jmp Securities ,

Prothena Co. plc (NASDAQ:PRTA) Given Average Rating of "Moderate Buy" by Analysts

Prothena Co. plc (NASDAQ:PRTA – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eight brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month target price among brokers […] ....

United States , Brandons Smith , Hideki Garren , Nisa Investment Advisors , Prothena Corporation , Prothena Company Profile , Lazard Asset Management , China Universal Asset Management Co , Tower Group , Cantor Fitzgerald , Prothena Co , Securities Exchange Commission , Get Free Report , Exchange Commission , Universal Asset Management , Investment Advisors , Asset Management , Stock Down , Get Free , Prothena Daily , Nasdaq Prta ,

Prothena (PRTA) Scheduled to Post Quarterly Earnings on Thursday

Prothena (NASDAQ:PRTA – Get Free Report) will release its earnings data after the market closes on Thursday, November 2nd. Analysts expect Prothena to post earnings of ($0.26) per share for the quarter. Prothena (NASDAQ:PRTA – Get Free Report) last announced its quarterly earnings results on Thursday, August 3rd. The biotechnology company reported ($1.03) EPS for […] ....

Hong Kong , United States , Karinl Walker , Hideki Garren , Hong Kong Ltd , Lazard Asset Management , Tower Research Capital , Osaic Holdings Inc , Cantor Fitzgerald , Securities Exchange Commission , Prothena Corporation , Prothena Company Profile , Get Free Report , Exchange Commission , Asset Management , Research Capital , Kong Ltd , Prothena Daily , Nasdaq Prta ,